/SMLR
SMLR Stock - Semler Scientific, Inc.
Healthcare|Medical - DevicesNASDAQ
$17.93+4.79%
+$0.82 (+4.79%) • Dec 19
58
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.66
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+240.2%upside
Target: $61.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SMLR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$17.75 – $18.11
TARGET (TP)$61.00
STOP LOSS$16.50
RISK/REWARD1:30.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.35
52W High$72.25
52W Low$15.90
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $56.29M | $68.18M | $56.69M | $53.03M | $38.60M |
| Gross Profit | $51.53M | $61.20M | $52.43M | $46.91M | $35.25M |
| Gross Margin | 91.5% | 89.8% | 92.5% | 88.5% | 91.3% |
| Operating Income | $20.93M | $22.26M | $17.20M | $19.45M | $15.96M |
| Net Income | $40.90M | $20.58M | $14.32M | $17.22M | $14.01M |
| Net Margin | 72.7% | 30.2% | 25.3% | 32.5% | 36.3% |
| EPS | $5.66 | $3.06 | $2.13 | $2.56 | $2.13 |
Company Overview
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
50%
Hold / Neutral
1
50%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
1 Bullish1 Neutral/Bearish
Price Targets
$73
Average Target
↑ 307.1% Upside
Now
$45
Low
$73
Average
$101
High
Based on 2 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| July 28th 2025 | Cantor Fitzgerald | Initiation | Overweight | - |
| July 8th 2025 | The Benchmark Company | Initiation | Buy | $101 |
| November 2nd 2022 | B. Riley Securities | Downgrade | Neutral | $45← $60 |
Earnings History & Surprises
SMLRBeat Rate
80%
Last 15 quarters
Avg Surprise
+461.6%
EPS vs Estimate
Beats / Misses
12/3
Last 12 quarters
Latest EPS
$1.07
Q4 2025
EPS Surprise History
Q1 24
+3.5%
$0.59vs$0.57
Q2 24
-24.3%
$0.78vs$1.03
Q3 24
+14.3%
$0.64vs$0.56
Q4 24
+94.6%
$0.72vs$0.37
Q1 25
+1211.5%
$3.41vs$0.26
Q2 25
No data
Q3 25
+5140.0%
$5.04vs$-0.10
Q4 25
+298.1%
$1.07vs$-0.54
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2026 | Nov 2, 2026 | — | — | — | — |
Q3 2026 | Aug 3, 2026 | — | — | — | — |
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 16, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | $-0.54 | $1.07 | +298.1% | ✓ BEAT |
Q3 2025 | Aug 4, 2025 | $-0.10 | $5.04 | +5140.0% | ✓ BEAT |
Q2 2025 | May 13, 2025 | — | $-0.76 | — | — |
Q1 2025 | Feb 18, 2025 | $0.26 | $3.41 | +1211.5% | ✓ BEAT |
Q4 2024 | Nov 4, 2024 | $0.37 | $0.72 | +94.6% | ✓ BEAT |
Q3 2024 | Aug 5, 2024 | $0.56 | $0.64 | +14.3% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $1.03 | $0.78 | -24.3% | ✗ MISS |
Q1 2024 | Mar 5, 2024 | $0.57 | $0.59 | +3.5% | ✓ BEAT |
Q4 2023 | Nov 9, 2023 | $0.51 | $0.78 | +52.9% | ✓ BEAT |
Q3 2023 | Aug 10, 2023 | $0.56 | $0.75 | +33.9% | ✓ BEAT |
Q2 2023 | May 10, 2023 | $0.58 | $0.63 | +8.6% | ✓ BEAT |
Q1 2023 | Mar 21, 2023 | $0.28 | $0.41 | +46.4% | ✓ BEAT |
Q4 2022 | Nov 1, 2022 | $0.29 | $0.46 | +58.6% | ✓ BEAT |
Q3 2022 | Aug 2, 2022 | $0.40 | $0.51 | +27.5% | ✓ BEAT |
Q2 2022 | May 2, 2022 | $0.48 | $0.41 | -14.6% | ✗ MISS |
Q1 2022 | Feb 28, 2022 | $0.45 | $0.33 | -26.7% | ✗ MISS |
Latest News
Semler Scientific Announces 37% Workforce Reduction, $1.2M Severance Costs And $1.6M Retention Program Ahead Of Pending Merger With Strive
📉 NegativeBenzinga•Dec 12, 2025, 09:10 PM
Semler Scientific Q3 EPS $1.07, Sales $7.491M Miss $7.865M Estimate
📉 NegativeBenzinga•Nov 12, 2025, 09:21 PM
Semler Scientific CFO Renae Cormier Resigns, Effective Oct. 16; CEO Douglas Murphy-Chutorian Named Interim CFO
📉 NegativeBenzinga•Oct 17, 2025, 08:13 PM
U.S. Justice Department Says Semler Scientific Inc. And Bard Peripheral Vascular, Inc. To Pay Nearly $37M To Resolve False Claims Act Allegations Relating To FloChec And QuantaFlo Devices
📉 NegativeBenzinga•Sep 26, 2025, 08:26 PM
Benchmark Maintains Buy on Semler Scientific, Lowers Price Target to $86
📈 PositiveBenzinga•Sep 23, 2025, 01:32 PM
Semler Scientific Says If Deal Terminated Under Some Conditions, Strive To Get Termination Fee Of $49M In Cash Or Bitcoin
➖ NeutralBenzinga•Sep 22, 2025, 09:37 PM•Also: , ,
Semler share are trading higher after the company announced it will be acquired by Strive.
📈 PositiveBenzinga•Sep 22, 2025, 01:13 PM
Strive to acquire fellow bitcoin treasury firm Semler Scientific in all-stock deal
➖ NeutralSeeking Alpha•Sep 22, 2025, 01:03 PM•Also: , ,
Strive To Acquire Semler Scientific In All-Stock Transaction, Equivalent To $90.52/Share; Strive Also Purchases 5,816 Bitcoin For Treasury
📈 PositiveBenzinga•Sep 22, 2025, 12:22 PM•Also: , ,
Trading Halt: Halted at 8:10:00 a.m. ET - Trading Halt: Halt News Pending
➖ NeutralBenzinga•Sep 22, 2025, 12:10 PM
Maxim Group Maintains Buy on Semler Scientific, Lowers Price Target to $80
📈 PositiveBenzinga•Sep 19, 2025, 04:45 PM
Semler Scientific Settles False Claims Act Case with DOJ and HHS Over Medicare Submissions; Co To Pay $29.75M Settlement With 4.25% Interest; Projects 50% Revenue Drop In Q4 2025 Vs Q3 2025, As Major Customer Cuts QuantaFlo Use
📉 NegativeBenzinga•Sep 16, 2025, 08:59 PM
Frequently Asked Questions about SMLR
What is SMLR's current stock price?
Semler Scientific, Inc. (SMLR) is currently trading at $17.93 per share. The stock has moved +4.79% today.
What is the analyst price target for SMLR?
The average analyst price target for SMLR is $61.00, based on 1 analyst.
What sector is Semler Scientific, Inc. in?
Semler Scientific, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is SMLR's market cap?
Semler Scientific, Inc. has a market capitalization of $0.27 billion, making it a small-cap company.
Does SMLR pay dividends?
No, Semler Scientific, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCATX
Perspective Therapeutics, Inc.
$2.75
Mkt Cap: $0.2B
DCTH
Delcath Systems, Inc.
$10.06
Mkt Cap: $0.3B
NPCE
NeuroPace, Inc.
$16.59
Mkt Cap: $0.6B
OMI
Owens & Minor, Inc.
$2.84
Mkt Cap: $0.2B
RXST
RxSight, Inc.
$12.03
Mkt Cap: $0.5B
SENS
Senseonics Holdings, Inc.
$6.15
Mkt Cap: $0.3B
SRDX
Surmodics, Inc.
$42.98
Mkt Cap: $0.6B
TCMD
Tactile Systems Technology, Inc.
$28.92
Mkt Cap: $0.6B
TMCI
Treace Medical Concepts, Inc.
$2.57
Mkt Cap: $0.2B
TOI
The Oncology Institute, Inc.
$3.50
Mkt Cap: $0.3B
Explore stocks similar to SMLR for comparison